Cocrystal Pharma Inc. logo

Cocrystal Pharma Inc. (COCP)

Market Open
12 Jun, 14:02
NASDAQ (CM) NASDAQ (CM)
$
1. 01
0
0%
$
10.76M Market Cap
- P/E Ratio
- Div Yield
21,095 Volume
-2.09 Eps
$ 1.01
Previous Close
Investors:
Add Transaction
Day Range
0.99 1.01
Year Range
0.86 2.67
Want to track COCP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day.

Accesswire | 1 year ago
Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy?

Cocrystal Pharma, Inc. (COCP) Now Trades Above Golden Cross: Time to Buy?

After reaching an important support level, Cocrystal Pharma, Inc. (COCP) could be a good stock pick from a technical perspective. COCP recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

Zacks | 2 years ago